| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer | See Remarks +1 more
1 company
Anish Bhatnagar is a Chief Executive Officer at SOLENO THERAPEUTICS INC. Recent SEC Form 4 filings include 4 buys and 5 sells.
Estimated insider holdings value: $24.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 53,505 | $27.49 | $1,471,049.04 | -8.0% | +84.1% | +85.4% | |
| Mar 31, 2022 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Buy | 60,000 | $0.00 | - | +16.2% | -11.8% | -36.0% | |
| Jan 21, 2022 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 39,033 | $0.37 | $14,559.31 | -9.5% | -45.1% | -55.9% | |
| Aug 19, 2016 | SLNO Soleno Therapeutics Inc | See Remarks | Buy | 10,000 | $0.96 | $9,600.00 | +13.6% | - | - | |
| May 13, 2016 | SLNO Soleno Therapeutics Inc | President And CEO | Buy | 5,000 | $1.15 | $5,745.00 | +7.3% | - | - | |
| Aug 12, 2015 | SLNO Soleno Therapeutics Inc | See Remarks | Buy | 10,000 | $1.64 | $16,400.00 | New | - | - |